Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jianjun Chen

Showing results (971-980 of 1,060) with videos related to

Pageof 106
Sort By:
Theranostics|August 15, 2022
RNA <i>N</i> -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancerBrandon Tan, Keren Zhou, Wei Liu, et al.
The Journal of Allergy and Clinical Immunology|February 9, 2025
Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trialMing Zheng, Di Wu, Yingshi Piao, et al.
Nature Communications|November 5, 2024
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunityHaiyan Zhang, Xiaojing Luo, Wei Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 24, 2024
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1Leisi Zhang, Honghai Zhang, Ting-Yu Wang, et al.
Leukemia|February 16, 2021
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemiaLe Xuan Truong Nguyen, Bin Zhang, Dinh Hoa Hoang, et al.
Blood|March 25, 2021
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent mannerMengdie Feng, Xueqin Xie, Guoqiang Han, et al.
Haematologica|April 13, 2019
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmCChenying Li, Lei Dong, Rui Su, et al.
Blood Cancer Discovery|April 17, 2023
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLLYiming Wu, Meiling Jin, Mike Fernandez, et al.
The Journal of Headache and Pain|July 29, 2022
Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patientsKe Li, Shuping Sun, Zhanyou Xue, et al.
The EMBO Journal|April 11, 2024
A Mettl16/m<sup>6</sup>A/mybl2b/Igf2bp1 axis ensures cell cycle progression of embryonic hematopoietic stem and progenitor cellsYunqiao Han, Kui Sun, Shanshan Yu, et al.
Pageof 106

Showing results (971-980 of 1,060) with videos related to

Sort By:
Pageof 106
Theranostics|August 15, 2022
RNA <i>N</i> -methyladenosine reader YTHDC1 is essential for TGF-beta-mediated metastasis of triple negative breast cancerBrandon Tan, Keren Zhou, Wei Liu, et al.
The Journal of Allergy and Clinical Immunology|February 9, 2025
Efficacy and safety of GR1802 in uncontrolled chronic rhinosinusitis with nasal polyps: Placebo-controlled phase 2 trialMing Zheng, Di Wu, Yingshi Piao, et al.
Nature Communications|November 5, 2024
YTHDF2 upregulation and subcellular localization dictate CD8 T cell polyfunctionality in anti-tumor immunityHaiyan Zhang, Xiaojing Luo, Wei Yang, et al.
Advanced Science (Weinheim, Baden-Wurttemberg, Germany)|December 24, 2024
Nuclear Control of Mitochondrial Homeostasis and Venetoclax Efficacy in AML via COX4I1Leisi Zhang, Honghai Zhang, Ting-Yu Wang, et al.
Leukemia|February 16, 2021
Cytoplasmic DROSHA and non-canonical mechanisms of MiR-155 biogenesis in FLT3-ITD acute myeloid leukemiaLe Xuan Truong Nguyen, Bin Zhang, Dinh Hoa Hoang, et al.
Blood|March 25, 2021
YBX1 is required for maintaining myeloid leukemia cell survival by regulating BCL2 stability in an m6A-dependent mannerMengdie Feng, Xueqin Xie, Guoqiang Han, et al.
Haematologica|April 13, 2019
Homoharringtonine exhibits potent anti-tumor effect and modulates DNA epigenome in acute myeloid leukemia by targeting SP1/TET1/5hmCChenying Li, Lei Dong, Rui Su, et al.
Blood Cancer Discovery|April 17, 2023
METTL3-Mediated m6A Modification Controls Splicing Factor Abundance and Contributes to Aggressive CLLYiming Wu, Meiling Jin, Mike Fernandez, et al.
The Journal of Headache and Pain|July 29, 2022
Pre-attack and pre-episode symptoms in cluster headache: a multicenter cross-sectional study of 327 Chinese patientsKe Li, Shuping Sun, Zhanyou Xue, et al.
The EMBO Journal|April 11, 2024
A Mettl16/m<sup>6</sup>A/mybl2b/Igf2bp1 axis ensures cell cycle progression of embryonic hematopoietic stem and progenitor cellsYunqiao Han, Kui Sun, Shanshan Yu, et al.
Pageof 106